US Companies
Every US company filing with the SEC, with its market value, valuation and one-year change.
Market value = latest close × shares outstanding on the newest 10-K or 10-Q cover, each share class at its own price.
P/E and 1-year change are calculated; revenue is the latest annual report as filed. Weight: share of the S&P 500 fund (SPY).
NeuroSense Therapeutics Ltd.
Latest values as text and table
NeuroSense Therapeutics Ltd.
Everything Plover Analytics holds for NeuroSense Therapeutics Ltd. (NRSN), SEC number 1875091: executive pay, financial statements, annual report text, insider trades, holders, results days, press releases, prices and shares outstanding. Source: SEC EDGAR.